Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Aditi Bagchi, MD, PhD
St. Jude Children's Research Hospital
Principal Investigator - Giles W. Robinson, MD
St. Jude Children's Research Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Lucille Packard Children'S Hospital Stanford
Palo Alto, California, United States
Sonia Partap, MD, MS,Recruiting - Orlando Health Arnold Palmer Hospital for Children
Orlando, Florida, United States
Avery Wright, DORecruiting - St. Joseph'S Children'S Hospital
Tampa, Florida, United States
Trisha Larkin, MDRecruiting - C.S. Mott Children'S Hospital, University of Michigan
Ann Arbor, Michigan, United States
Santhosh Upadhyaya, MDRecruiting - Children'S Hospital and Clinics of Minnesota
Minneapolis, Minnesota, United States
Anne Bendel, MDRecruiting - St. Jude Children'S Research Hospital
Memphis, Tennessee, United States
Aditi Bagchi, MD, PhDGiles W. Robinson, MDRecruiting - Ut Southwestern Medical Center/harold C Simmons Comprehensive Cancer Center
Dallas, Texas, United States
Daniel Bowers, MDRecruiting - Cook Children'S Medical Center
Fort Worth, Texas, United States
Sibo Zhao, MDRecruiting - Texas Children'S Hospital
Houston, Texas, United States
Murali Chintagumpala, MDRecruiting - Primary Children'S Hospital
Salt Lake City, Utah, United States
Nicholas Whipple, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Dec 2022
- Primary completion
- 31 Jul 2035
- Completion
- 31 Jul 2035
- Last update posted
- 12 Feb 2026
- Registered enrollment
- 130
- Registry id
- NCT05535166
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.